FIPI
FIPI is a phospholipase D (PLD) inhibitor with an IC50 for PLD1 and PLD2 of about 25 nM. FIPI regulates cytoskeletal recombination, cell diffusion and chemotaxis. FIPI can be used in cancer research. In addition, FIPI can enhance the secretion and aggregation of platelet dense particles, inhibit thrombosis, reduce ischemic stroke infarct volume and improve nerve function[1][2][3][4].
Product Specifications
CAS Number
939055-18-2
Product Name Alternative
5-Fluoro-2-indolyl deschlorohalopemide
UNSPSC
12352005
Target
Phospholipase
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
COVID-19-immunoregulation
Field of Research
Cancer; Inflammation/Immunology; Neurological Disease; Cardiovascular Disease
Assay Protocol
https://www.medchemexpress.com/FIPI.html
Purity
98.00
Solubility
DMSO : 3.33 mg/mL (ultrasonic)
Smiles
O=C(NCCN1CCC(CC1)N2C3=CC=CC=C3NC2=O)C4=CC5=C(C=CC(F)=C5)N4
Molecular Formula
C23H24FN5O2
Molecular Weight
421.47
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
PLD
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Thymidylate Synthase (5-FU Resistance Marker) (TYMS/1884), CF647 conjugate, 0.1mg/mL
Calpain 1 (CAPN1/1530), CF740 conjugate, 0.1mg/mL
![ACE Recombinant Rabbit Monoclonal Antibody [JM59-32]](https://cdn.genprice.uk/products/992/68dd1c8b061270361ea817a6/imageurl/et1705-36.webp)